相似文献
1
Delivery of local therapeutics to the brain: working toward advancing treatment for malignant gliomas.
Ther Deliv. 2015 Mar;6(3):353-69. doi: 10.4155/tde.14.114.
2
Current status of local therapy in malignant gliomas--a clinical review of three selected approaches.
Pharmacol Ther. 2013 Sep;139(3):341-58. doi: 10.1016/j.pharmthera.2013.05.003. Epub 2013 May 18.
3
Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
Drug Resist Updat. 2015 Mar;19:1-12. doi: 10.1016/j.drup.2015.02.002. Epub 2015 Mar 6.
4
Targeted Local Therapy for Management of Intracranial High-Grade Gliomas.
Prog Neurol Surg. 2018;32:159-171. doi: 10.1159/000469688. Epub 2018 Jul 10.
5
Novel therapies for malignant gliomas: a local affair?
Neurosurg Focus. 2006 Apr 15;20(4):E9.
6
Endovascular therapies for malignant gliomas: Challenges and the future.
J Clin Neurosci. 2016 Apr;26:26-32. doi: 10.1016/j.jocn.2015.10.019. Epub 2016 Feb 5.
7
Convection-enhanced Delivery of Therapeutics for Malignant Gliomas.
Neurol Med Chir (Tokyo). 2017 Jan 15;57(1):8-16. doi: 10.2176/nmc.ra.2016-0071. Epub 2016 Dec 15.
8
Local strategies and delivery systems for the treatment of malignant gliomas.
J Drug Target. 2019 Apr;27(4):367-378. doi: 10.1080/1061186X.2018.1509982. Epub 2018 Sep 19.
9
The neurosurgeon as local oncologist: cellular and molecular neurosurgery in malignant glioma therapy.
Neurosurgery. 2003 Jun;52(6):1411-22; discussion 1422-4. doi: 10.1227/01.neu.0000064808.27512.cf.
10
Novel therapies for malignant gliomas.
Neurol Clin. 2007 Nov;25(4):1141-71, x. doi: 10.1016/j.ncl.2007.07.012.
引用本文的文献
1
Focused ultrasound-mediated APOE4 knockdown in mouse brain.
Alzheimers Dement. 2025 Jul;21(7):e70464. doi: 10.1002/alz.70464.
2
Nanoparticle-in-Hydrogel Delivery System for the Sequential Release of Two Drugs.
Pharmaceutics. 2025 Jan 17;17(1):127. doi: 10.3390/pharmaceutics17010127.
3
Immunotherapy for glioblastoma: current state, challenges, and future perspectives.
Cell Mol Immunol. 2024 Dec;21(12):1354-1375. doi: 10.1038/s41423-024-01226-x. Epub 2024 Oct 15.
4
Prospects of Synergy: Local Interventions and CAR T Cell Therapy in Solid Tumors.
BioDrugs. 2024 Sep;38(5):611-637. doi: 10.1007/s40259-024-00669-y. Epub 2024 Jul 30.
5
Nanomaterials as drug delivery agents for overcoming the blood-brain barrier: A comprehensive review.
ADMET DMPK. 2023 Oct 31;12(1):63-105. doi: 10.5599/admet.2043. eCollection 2024.
6
Peritumoral brain zone in glioblastoma: biological, clinical and mechanical features.
Front Immunol. 2024 Feb 29;15:1347877. doi: 10.3389/fimmu.2024.1347877. eCollection 2024.
7
Focused ultrasound-mediated delivery of viral neuronal tracers in marmosets.
Cell Rep Methods. 2024 Feb 26;4(2):100719. doi: 10.1016/j.crmeth.2024.100719.
8
Resveratrol Alleviates the Early Challenges of Implant-Based Drug Delivery in a Human Glial Cell Model.
Int J Mol Sci. 2024 Feb 8;25(4):2078. doi: 10.3390/ijms25042078.
9
A Stable Micellar Formulation of RAD001 for Intracerebroventricular Delivery and the Treatment of Alzheimer's Disease and Other Neurological Disorders.
Int J Mol Sci. 2023 Dec 14;24(24):17478. doi: 10.3390/ijms242417478.
10
Lipid Nanoparticles Deliver mRNA to the Brain after an Intracerebral Injection.
Biochemistry. 2023 Dec 19;62(24):3533-3547. doi: 10.1021/acs.biochem.3c00371. Epub 2023 Sep 20.
本文引用的文献
1
A multicenter phase I/II study of the BCNU implant (Gliadel(®) Wafer) for Japanese patients with malignant gliomas.
Neurol Med Chir (Tokyo). 2014;54(4):290-301. doi: 10.2176/nmc.oa2013-0112. Epub 2013 Nov 29.
2
A new angle on blood-CNS interfaces: a role for connexins?
FEBS Lett. 2014 Apr 17;588(8):1259-70. doi: 10.1016/j.febslet.2014.02.060. Epub 2014 Mar 12.
3
Combining microbubbles and ultrasound for drug delivery to brain tumors: current progress and overview.
Theranostics. 2014 Feb 12;4(4):432-44. doi: 10.7150/thno.8074. eCollection 2014.
4
The combination of IDH1 mutations and MGMT methylation status predicts survival in glioblastoma better than either IDH1 or MGMT alone.
Neuro Oncol. 2014 Sep;16(9):1263-73. doi: 10.1093/neuonc/nou005. Epub 2014 Feb 6.
5
When gross total resection of a glioblastoma is possible, how much resection should be achieved?
World Neurosurg. 2014 Jul-Aug;82(1-2):e257-65. doi: 10.1016/j.wneu.2014.01.019. Epub 2014 Feb 6.
6
Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastoma.
Neuro Oncol. 2014 Jan;16(1):113-22. doi: 10.1093/neuonc/not137. Epub 2013 Nov 26.
7
Multi-institutional validation of a preoperative scoring system which predicts survival for patients with glioblastoma.
J Clin Neurosci. 2013 Oct;20(10):1422-6. doi: 10.1016/j.jocn.2013.02.007. Epub 2013 Aug 6.
8
Prospective study of carmustine wafers in combination with 6-month metronomic temozolomide and radiation therapy in newly diagnosed glioblastoma: preliminary results.
J Neurosurg. 2013 Apr;118(4):821-9. doi: 10.3171/2012.12.JNS111893. Epub 2013 Jan 25.
9
Multiple resections for patients with glioblastoma: prolonging survival.
J Neurosurg. 2013 Apr;118(4):812-20. doi: 10.3171/2012.9.JNS1277. Epub 2012 Oct 19.
10
Results of phase I study of a multi-modality treatment for newly diagnosed glioblastoma multiforme using local implantation of concurrent BCNU wafers and permanent I-125 seeds followed by fractionated radiation and temozolomide chemotherapy.
J Neurooncol. 2012 Jul;108(3):521-5. doi: 10.1007/s11060-012-0854-z. Epub 2012 Apr 1.
Zotero 插件